DEALS
Zhong Lun Advised on Grand Flight’s Led Investment in Peijia Medical
Zhong Lun Advised on Grand Flight’s Led Investment in Peijia Medical
Release time：2019-11-08
Voice Announcements
In November 2019, Peijia Medical, a leading Chinese cardio-cerebral-vascular disease treatment platform, announced that it had completed the US$100 million Series C financing led by Grand Flight Investment, which is one of the largest deals in recent years in the interventional medical area, or even in the medical device area, in China.
Zhong Lun Law Firm acted as the legal counsel to Grand Flight Investment in this transaction. The legal team from Zhong Lun was led by Anthony Zhao and Luke Zhang, and included Cynthia Yuan, etc.
Professionals
-
-
Anthony ZHAO
Equity Partner
ShanghaiPractices： Hong Kong & Overseas Capital Markets,Private Equity & Investment Funds,Cross-border Investment/M&AIndustries： Telecommunications & Internet,Information & Intelligence Technology,Healthcare,Pharmaceuticals & Life Sciences,Education & Training,Media-Sports & Entertainment,Banking & Financial Services,Financial Innovation & Fintech -
Anthony ZHAO
Equity Partner
Shanghai
-
-
-
Luke ZHANG
Equity Partner
ShanghaiPractices： Private Equity & Investment Funds,Cross-border Investment/M&A,Hong Kong & Overseas Capital MarketsIndustries： Telecommunications & Internet,Information & Intelligence Technology,Pharmaceuticals & Life Sciences,Healthcare,Education & Training,Media-Sports & Entertainment,Financial Innovation & Fintech -
Luke ZHANG
Equity Partner
Shanghai
-